000 02397 a2200757 4500
005 20250513150822.0
264 0 _c19980909
008 199809s 0 0 eng d
022 _a0022-2623
024 7 _a10.1021/jm9802259
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKlutchko, S R
245 0 0 _a2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cAug 1998
300 _a3276-92 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _a3T3 Cells
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xchemical synthesis
650 0 4 _aBiotransformation
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCisplatin
_xtherapeutic use
650 0 4 _aEnzyme Inhibitors
_xchemical synthesis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aMolecular Conformation
650 0 4 _aMolecular Structure
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aPlatelet-Derived Growth Factor
_xpharmacology
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aPyrimidinones
_xchemical synthesis
650 0 4 _aRats
650 0 4 _aReceptor Protein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aStructure-Activity Relationship
650 0 4 _aTransplantation, Heterologous
650 0 4 _aTumor Cells, Cultured
700 1 _aHamby, J M
700 1 _aBoschelli, D H
700 1 _aWu, Z
700 1 _aKraker, A J
700 1 _aAmar, A M
700 1 _aHartl, B G
700 1 _aShen, C
700 1 _aKlohs, W D
700 1 _aSteinkampf, R W
700 1 _aDriscoll, D L
700 1 _aNelson, J M
700 1 _aElliott, W L
700 1 _aRoberts, B J
700 1 _aStoner, C L
700 1 _aVincent, P W
700 1 _aDykes, D J
700 1 _aPanek, R L
700 1 _aLu, G H
700 1 _aMajor, T C
700 1 _aDahring, T K
700 1 _aHallak, H
700 1 _aBradford, L A
700 1 _aShowalter, H D
700 1 _aDoherty, A M
773 0 _tJournal of medicinal chemistry
_gvol. 41
_gno. 17
_gp. 3276-92
856 4 0 _uhttps://doi.org/10.1021/jm9802259
_zAvailable from publisher's website
999 _c9669080
_d9669080